core 2 transferase inhibitors (Inflazyme)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namecore 2 transferase inhibitors (Inflazyme)
Drug Alias Namecore 2 GlcNAc-T inhibitors (GLYCODesign)core 2 transferase inhibbitors (GLYCODesign)core 2 transferase inhibitors (Seikagaku/GLYCODesign)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransferases inhibitors
TargetsTransferases
Therapy Area/IndicationsInflammationDiabetes MellitusCardiovascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlycodesign Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlycodesign IncInflazyme Pharmaceuticals LtdSeikagaku Corp
Active IndicationsN/A
Inactive IndicationsInflammationDiabetes MellitusCardiovascular Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A